A Likelihood Ratio Test Based Method for Signal Detection With Application to FDA’s Drug Safety Data
Lan Huang, Jyoti N. Zalkikar, Ram Chandra Tiwari · Journal of the American Statistical Association · 2011
Several statistical methods that are available in the literature to analyze postmarket safety databases, such as the U.S. Federal Drug Administration’s (FDA) adverse event reporting system (AERS), for identifying drug-event combinations with disproportionately high frequencies, are subject to high false discovery rates. Here, we propose a likelihood ratio test (LRT) based method and show, via an extensive simulation study, that the proposed method while retaining good power and sensitivity for identifying signals, controls both the Type I error and false discovery rates. The application of the LRT method to the AERS database is illustrated using two datasets; a small dataset consisting of suicidal behavior and mood change-related AE cases for the drug Montelukast, and a large dataset consisting of all possible AE cases reported to FDA during 2004–2008 for the drug Heparin. This article has supplementary material online.
Cited by 101 works. doi:10.1198/jasa.2011.ap10243
Authors
References
- Journal of the Royal Statistical Society.
- Contingency Tables Involving Small Numbers and the χ2 Test
- A spatial scan statistic
- Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
- A Bayesian neural network method for adverse drug reaction signal generation
- Modified Randomization Tests for Nonparametric Hypotheses
- Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System
- Applied Spatial Statistics for Public Health Data
- Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA??s Spontaneous Reports Database
- The reporting odds ratio and its advantages over the proportional reporting ratio